Lakefront Biotherapeutics (LKFT)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 859 |
| % of all portfolios: | 0.006% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q1 2024 | |||||
| ≡ | David Einhorn - Greenlight Capital | Reduce 1.69% | 2,750 | 0.00 | |
| Q2 2023 | |||||
| ≡ | David Einhorn - Greenlight Capital | Reduce 0.79% | 1,200 | 0.00 | |
| Q1 2023 | |||||
| ≡ | David Einhorn - Greenlight Capital | Reduce 2.57% | 3,990 | 0.01 | |
| Q2 2022 | |||||
| ≡ | David Einhorn - Greenlight Capital | Reduce 8.62% | 13,812 | 0.06 | |
| Q1 2022 | |||||
| ≡ | David Einhorn - Greenlight Capital | Reduce 13.41% | 24,800 | 0.10 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.